Treating Hepatitis C in CRF Using Sofosbuvir and Daclatasvir

NCT03063879 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

95

Enrollment

OTHER

Sponsor class

Conditions

Hepatitis C, Chronic
Chronic Renal Failure

Interventions

DRUG: Sofosbuvir 400 mg and daclatasvir 60 mg

Sponsor

Tehran University of Medical Sciences

Collaborators

[object Object]
[object Object]
[object Object]